Coherus Oncology (CHRS) Interest Coverage Ratio (2016 - 2025)
Historic Interest Coverage Ratio for Coherus Oncology (CHRS) over the last 13 years, with Q3 2025 value amounting to 19.07.
- Coherus Oncology's Interest Coverage Ratio fell 1504.42% to 19.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 3.69, marking a year-over-year increase of 6586.81%. This contributed to the annual value of 4.11 for FY2024, which is 1796.28% up from last year.
- Per Coherus Oncology's latest filing, its Interest Coverage Ratio stood at 19.07 for Q3 2025, which was down 1504.42% from 19.98 recorded in Q2 2025.
- In the past 5 years, Coherus Oncology's Interest Coverage Ratio ranged from a high of 2.32 in Q4 2024 and a low of 29.63 during Q1 2021
- Its 5-year average for Interest Coverage Ratio is 10.75, with a median of 6.98 in 2023.
- Over the last 5 years, Coherus Oncology's Interest Coverage Ratio had its largest YoY gain of 13580.62% in 2024, and its largest YoY loss of 43173.33% in 2024.
- Over the past 5 years, Coherus Oncology's Interest Coverage Ratio (Quarter) stood at 6.83 in 2021, then grew by 19.63% to 5.49 in 2022, then decreased by 18.26% to 6.49 in 2023, then soared by 135.81% to 2.32 in 2024, then crashed by 920.69% to 19.07 in 2025.
- Its Interest Coverage Ratio stands at 19.07 for Q3 2025, versus 19.98 for Q2 2025 and 21.13 for Q1 2025.